Skip to main content
Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus

Fig. 1

Change of HbA1c level over 6 months in patients with baseline HbA1c levels ≥ 9% (75 mmol/mol) (n = 39) (A) and those with lower baseline HbA1c levels (n = 29) (B). Data were HbA1c level under medical nutrition therapy without antihyperglycemic medications. In patients who started an antihyperglycemic medication within 6 months, only the data before the start were plotted

Back to article page